Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Thromboembolism of Vein VTE in Colorectal Cancer 1Thromboembolism 1Pulmonary Embolism 1Pancreatic Neoplasms 1

Interventions

Tinzaparin 3Gemcitabine 3Heparin, Low-Molecular-Weight 2Enoxaparin 2Dalteparin 2130-nm albumin-bound paclitaxel 2palbociclib 1isoquercitrin 1Watchful Waiting 1Rivaroxaban 1PEGPH20 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thromboembolism × isoquercitrin × Gastrointestinal × Clear all
NCT06861088 2026-02-02

CATIQ P3

Quercis Pharma AG

Phase 3 Recruiting
480 enrolled
Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Thromboembolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡